News
Startup Commercializes UCLA "Lung Simulation" Technology
Bosley recently finalized the lung phantom’s first prototype, which he will take to partners at UCLA; next, he hopes to start printing lungs from actual patients’ CT scans and let oncologists test the simulator. The patent-pending technology, owned by UCF and UCLA and is licensed to SegAna, will cost in the $8,000 range, Bosley said. It can be used as a teaching tool, or for planning patients’ radiation treatment.
UCLA Launches Campus-wide 2017 Biomedical Competition
The 2017 Fund for Innovation will be the first campus-wide biomedical competition with three tracks: therapeutics, medical devices/diagnostics, and digital health. View the brochure for dates and more information.
New Report: UCLA Among Nation’s Best for Commercializing Research
CLA is No. 1 in the nation when it comes to the number of startup companies launched as a result of campus research, according to the rankings by the Milken Institute, an independent economic think tank based in Santa Monica.